Related Experiment Videos
[The heart and central nervous system. Benzodiazepines in cardiovascular psychosomatic medicine]
1Istituto di Patologia Speciale Medica e Metodologia Clinica, Università degli Studi di Bologna.
Insights
Central nervous system (CNS) alterations correlate with cardiovascular changes, particularly in Type A behavior and stress. Benzodiazepines show promise in managing stress-related cardiovascular disorders.
Area of Science:
- Neuroscience
- Cardiology
- Psychosomatic Medicine
Context:
- Established link between central nervous system (CNS) alterations and cardiovascular dysfunction.
- Type A behavior pattern is a significant risk factor for coronary heart disease.
- Stress activates neurohormonal pathways implicated in cardiovascular pathogenesis.
Purpose:
- To explore the role of centrally acting drugs, specifically benzodiazepines, in managing stress-induced cardiovascular disorders.
- To investigate the potential of certain benzodiazepine molecules in controlling cardiac dysfunction.
Summary:
- Benzodiazepines can mitigate the stress response and its psychosomatic effects on the cardiovascular system.
- Some benzodiazepine compounds exhibit affinity for cardiac muscle, suggesting a direct role in suppressing stress-related cardiovascular events.
- This highlights a potential therapeutic avenue for stress-related cardiovascular conditions.
Impact:
- Provides insight into the neurobiological mechanisms underlying stress and cardiovascular disease.
- Suggests a pharmacological approach for managing psychosomatic cardiovascular involvement.
- Opens avenues for developing targeted therapies for stress-induced cardiac conditions.
Abstract:
In certain clinical situations, a close correlation between CNS alterations and changes in the normal functioning of the cardiovascular apparatus has been well documented. Thus, it has been shown that a certain type of behavior, termed type A, is significantly associated with coronary disease and other cardiovascular disorders. Stress, too, by activating complex neurohormonal mechanisms can become an important factor in the pathogenesis of these disorders. Systematic management of these disorders has not yet been worked out but centrally acting drugs, and especially benzodiazepines, have been found useful in reducing the stress reaction and the consequent psychosomatic cardiovascular involvement. Some molecules of this class of drugs have been shown to possess marked affinity for the cardiac muscle and to act effectively in control and suppression of the cardiovascular disorders following upon the neuro-hormonal activation caused by stressful events.